How to buy Medtronic (MDT) shares in Australia
Learn how to easily invest in Medtronic shares.
Medtronic PLC (MDT) is a leading medical devices business with stocks listed in the US. It opened the day at US$78.9 after a previous close of US$79. During the day the price has varied from a low of USD78.4 to a high of USD79.05. The latest price was USD78.86 (25 minute delay). Medtronic is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Medtronic
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Medtronic. Find the share by name or ticker symbol: MDT. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medtronic reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$79, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Medtronic, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Medtronic. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
What's in this guide?
- Medtronic key stats
- Compare share trading platforms
- Is Medtronic stock a buy or sell?
- Medtronic performance over time
- Is Medtronic suitable for ethical investing?
- Are Medtronic shares over-valued?
- Medtronic's financials
- How volatile are Medtronic shares?
- Does Medtronic pay a dividend?
- Have Medtronic shares ever split?
- Other common questions
Medtronic stock price (NYSE:MDT)Use our graph to track the performance of MDT stocks over time.
Have Medtronic's shares ever split?
Medtronic's shares were split on a 2:1 basis on 27 September 1999. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Medtronic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Medtronic shares which in turn could have impacted Medtronic's share price.
Medtronic shares at a glance
|52-week range||US$68.84 - US$90.5279|
|50-day moving average||US$74.9124|
|200-day moving average||US$81.9821|
|Dividend yield||US$2.74 (3.49%)|
|Earnings per share (TTM)||US$3.08|
Medtronic price performance over time
|1 week (2023-11-21)||0.31%|
|1 month (2023-10-27)||13.58%|
|3 months (2023-08-28)||-3.11%|
|6 months (2023-05-26)||-3.19%|
|1 year (2022-11-28)||3.59%|
|2 years (2021-11-26)||-28.99%|
|3 years (2020-11-27)||-31.18%|
|5 years (2018-11-28)||-17.31%|
Compare trading platforms to buy Medtronic shares
Is it a good time to buy Medtronic stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Medtronic under- or over-valued?
Valuing Medtronic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medtronic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medtronic's P/E ratio
Medtronic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Medtronic shares trade at around 26x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medtronic's PEG ratio
Medtronic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0399. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medtronic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medtronic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$8.7 billion (£6.8 billion).
The EBITDA is a measure of a Medtronic's overall financial performance and is widely used to measure a its profitability.
Medtronic share price volatility
Over the last 12 months, Medtronic's shares have ranged in value from as little as US$68.84 up to US$90.5279. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medtronic's is 0.722. This would suggest that Medtronic's shares are less volatile than average (for this exchange).
|Revenue TTM||US$32 billion|
|Operating margin TTM||20.77%|
|Gross profit TTM||US$21.7 billion|
|Return on assets TTM||4.23%|
|Return on equity TTM||7.96%|
|Market capitalisation||US$105.1 billion|
TTM: trailing 12 months
Medtronic share dividends
Dividend payout ratio: 41.39% of net profits
Recently Medtronic has paid out, on average, around 41.39% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.49% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medtronic shareholders could enjoy a 3.49% return on their shares, in the form of dividend payments. In Medtronic's case, that would currently equate to about $2.74 per share.
While Medtronic's payout ratio might seem fairly standard, it's worth remembering that Medtronic may be investing much of the rest of its net profits in future growth.
Medtronic's most recent dividend payout was on 13 October 2023. The latest dividend was paid out to all shareholders who bought their shares by 21 September 2023 (the "ex-dividend date").
Medtronic's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medtronic.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Medtronic's total ESG risk score
Total ESG risk: 26.86
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medtronic's overall score of 26.86 (as at 01/01/2019) is nothing to write home about – landing it in it in the 41st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Medtronic is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Medtronic's environmental score
Environmental score: 4.07/100
Medtronic's environmental score of 4.07 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Medtronic's social score
Social score: 15.28/100
Medtronic's social score of 15.28 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Medtronic's governance score
Governance score: 9/100
Medtronic's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Medtronic is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Medtronic's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Medtronic scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Medtronic hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||26.86|
|Total ESG percentile||40.62|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||3|
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stocks similar to Medtronic
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Nov 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert